Breaking News Instant updates and real-time market news.

LGND

Ligand

$108.10

1.88 (1.77%)

15:23
12/21/16
12/21
15:23
12/21/16
15:23

Ligand accused of unethical behavior in letter sent to U.S. Senate

In a letter to U.S. Senate Special Committee on Aging members Susan Collins and Claire McCaskill, The Lantern Foundation's Emmanuel Lemelson commended them for "uncovering unethical and sometimes criminal behavior on the part of unethical pharmaceutical companies" and claimed Ligand is "the industry's most significant abuser of these standards and laws." According to Lemelson: "These include multiple abuses and violations of existing pharmaceutical classification, reimbursement, and accounting statutes and standards by Ligand. In particular, Ligand Pharmaceuticals' so called "licensing" model is a nexus for a new breed of unethical pharmaceutical companies whose primary goal is to reap extraordinary profits on the backs of patients, taxpayers and shareholders by abusing the Orphan Drug Act of 1983 as well as a litany of accounting loopholes."

  • 21

    Dec

LGND Ligand
$108.10

1.88 (1.77%)

09/07/16
09/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Hold from Underperform at Jefferies with analyst Jason Gammel citing valuation and improving financial metrics. 2. DineEquity (DIN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Chris O'Cull saying the stock has reached a good entry point, while its risk/reward ratio is "compelling." 3. Gaming and Leisure Properties (GLPI) upgraded to Overweight at Morgan Stanley. 4. Aviva (AV) upgraded to Buy from Neutral at UBS with the firm saying the company is positioned to be the risk-adjusted dividend leader in the sector. 5. Ligand (LGND) upgraded to Hold from Sell at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
HCWC
10/05/16
NO CHANGE
Target $160
HCWC
Buy
Ligand price target raised to $160 from $146 at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther raised her price target for Ligand Pharmaceuticals to $160 citing three recent positive events, namely positive Phase II focal segmental glomerulosclerosis data from partner Retrophin, the beginning of a Phase II clinical trial with LGD-6972 for the treatment of type 2 diabetes and the licensing of several therapeutic programs to Seelos. Werther keeps a Buy rating on Ligand.
10/10/16
ROTH
10/10/16
NO CHANGE
Target $154
ROTH
Buy
Ligand price target raised to $154 after Carnexiv approval at Roth Capital
Roth Capital analyst Joseph Pantginis raised his price target on Ligand to $154 from $150 after partner Lundbeck announced that the FDA approved Carnexiv injection as a short-term replacement therapy for oral carbamazepine formulations in adults with certain seizure types. Ligand will receive a $1.25M milestone payment this quarter and is entitled to receive a 2.75% royalty on sales of the drug, noted Pantginis, who keeps a Buy rating on Ligand shares.
11/07/16
SPHN
11/07/16
NO CHANGE
Target $125
SPHN
Overweight
Ligand price target lowered to $125 from $150 at Stephens
Stephens analyst Drew Jones lowered his price target for Ligand to $125 from $150 on valuation. The analyst notes that the company reported mixed Q3 results as revenue softness led to lowered guidance for the year. Nonetheless, he reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

MRAM

Everspin Technologies

$6.52

-0.09 (-1.36%)

12:12
09/20/19
09/20
12:12
09/20/19
12:12
Conference/Events
Everspin Technologies management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 12

    Nov

SAIC

SAIC

$84.64

0.76 (0.91%)

12:11
09/20/19
09/20
12:11
09/20/19
12:11
Recommendations
SAIC analyst commentary  »

SAIC recompete bid on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$86.18

1.5 (1.77%)

12:11
09/20/19
09/20
12:11
09/20/19
12:11
Conference/Events
Alnylam management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 02

    Oct

  • 04

    Feb

SNPS

Synopsys

$137.26

0.09 (0.07%)

12:10
09/20/19
09/20
12:10
09/20/19
12:10
Conference/Events
Synopsys management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

TYL

Tyler Technologies

$259.35

-0.22 (-0.08%)

12:10
09/20/19
09/20
12:10
09/20/19
12:10
Conference/Events
Tyler Technologies management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

AAPL

Apple

$220.96

0.05 (0.02%)

, MCD

McDonald's

$210.55

-0.01 (-0.00%)

12:02
09/20/19
09/20
12:02
09/20/19
12:02
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks are mixed at…

AAPL

Apple

$220.96

0.05 (0.02%)

MCD

McDonald's

$210.55

-0.01 (-0.00%)

FB

Facebook

$190.17

0.02 (0.01%)

MDR

McDermott

$2.70

1.12 (70.89%)

CRC

California Resources

$11.86

1.96 (19.80%)

ROKU

Roku

$114.30

-19.41 (-14.52%)

W

Wayfair

$123.39

-5.275 (-4.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 24

    Sep

  • 27

    Oct

SCS

Steelcase

$18.34

1.57 (9.36%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
Steelcase rises 9.6% »

Steelcase is up 9.6%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 15

    Oct

  • 16

    Oct

IBN

ICICI Bank

$11.88

1.11 (10.31%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
ICICI Bank rises 10.2% »

ICICI Bank is up 10.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRC

California Resources

$11.75

1.85 (18.69%)

12:00
09/20/19
09/20
12:00
09/20/19
12:00
Hot Stocks
California Resources rises 18.8% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$45.72

0.83 (1.85%)

11:54
09/20/19
09/20
11:54
09/20/19
11:54
Upgrade
Sanofi rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

TSLA

Tesla

$242.92

-3.59 (-1.46%)

11:50
09/20/19
09/20
11:50
09/20/19
11:50
Options
Bearish Dec put spread collar in Tesla opened for a small debit »

Bearish Dec put spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SNY

Sanofi

$45.61

0.72 (1.60%)

11:46
09/20/19
09/20
11:46
09/20/19
11:46
Upgrade
Sanofi rating change  »

Sanofi upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 27

    Sep

  • 02

    Oct

CRZBY

Commerzbank

$0.00

(0.00%)

11:46
09/20/19
09/20
11:46
09/20/19
11:46
Hot Stocks
Commerzbank develops draft of new strategy, to cut 4,300 jobs »

Commerzbank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHHBY

Roche

$0.00

(0.00%)

11:45
09/20/19
09/20
11:45
09/20/19
11:45
Hot Stocks
Roche reports FDA approves cobas Babesia test »

Roche announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

PBR

Petrobras

$14.44

-0.09 (-0.62%)

11:42
09/20/19
09/20
11:42
09/20/19
11:42
Periodicals
Petrobras suffers increase in fuel theft from pipelines, Reuters reports »

Petrobras is confronting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$116.20

-17.51 (-13.10%)

11:40
09/20/19
09/20
11:40
09/20/19
11:40
Options
Roku leads single stock option volume with over 250K contracts in 90 minutes »

Roku leads single stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:40
09/20/19
09/20
11:40
09/20/19
11:40
General news
More from Rosengren: he reiterated his dissent »

More from Rosengren: he…

RYAAY

Ryanair

$62.91

0.43 (0.69%)

11:38
09/20/19
09/20
11:38
09/20/19
11:38
Hot Stocks
Ryanair U.K. pilots union cancels five further strike days »

The British Airline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDR

McDermott

$2.74

1.16 (73.42%)

11:35
09/20/19
09/20
11:35
09/20/19
11:35
Recommendations
McDermott analyst commentary  »

McDermott's plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

VAL

Valaris

$6.76

-0.01 (-0.15%)

11:35
09/20/19
09/20
11:35
09/20/19
11:35
Options
Valaris Plc put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
09/20/19
09/20
11:35
09/20/19
11:35
General news
NY Fed announced it will conduct daily repo operations »

NY Fed announced it will…

ADBE

Adobe

$278.77

-2.44 (-0.87%)

11:28
09/20/19
09/20
11:28
09/20/19
11:28
Hot Stocks
Lucas announces departure from Adobe and Marketo »

Steve Lucas announced in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

TELL

Tellurian

$8.75

0.165 (1.92%)

11:25
09/20/19
09/20
11:25
09/20/19
11:25
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHV

Achieve Life Sciences

$2.21

0.095 (4.49%)

11:25
09/20/19
09/20
11:25
09/20/19
11:25
Conference/Events
Achieve Life Sciences to host investor day »

Investor day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

FB

Facebook

$191.40

1.25 (0.66%)

, SNAP

Snap

$16.91

0.04 (0.24%)

11:25
09/20/19
09/20
11:25
09/20/19
11:25
Conference/Events
FBN Securities Tech/Internet analyst to hold a group luncheon »

technology and Internet…

FB

Facebook

$191.40

1.25 (0.66%)

SNAP

Snap

$16.91

0.04 (0.24%)

TWTR

Twitter

$43.65

0.71 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.